Products & Services · Increased revenue
Test Revenue — Increased revenue
Natera, Inc. Test Revenue — Increased revenue increased by 77.8% to $61.00M in Q1 2026 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementSegment
CategoryEfficiency
SignalHigher is better
VolatilityModerate
First reportedQ1 2025
Last reportedQ1 2026
How to read this metric
An increase indicates improved billing cycle efficiency or higher success in resolving outstanding accounts receivable, while a decrease may signal collection delays or increased payment disputes.
Detailed definition
This metric represents the portion of revenue recognized from diagnostic tests delivered in prior reporting periods that...
Peer comparison
Similar to 'cash collections from prior period sales' or 'revenue recognized from deferred billing' seen in other diagnostic and healthcare service providers.
Metric ID:
ntra_segment_test_revenue_increased_revenueHistorical Data
2 periods
| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | $34.30M | $61.00M |
| QoQ Change | — | +77.8% |
| YoY Change | — | +77.8% |
Range$34.30M – $61.00M
Avg YoY Growth+77.8%
Median YoY Growth+77.8%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Natera, Inc.'s test revenue — increased revenue?
- Natera, Inc. (NTRA) reported test revenue — increased revenue of $61.00M in Q1 2026.
- What does test revenue — increased revenue mean?
- Revenue recognized from diagnostic tests performed in previous periods that has now been fully paid by customers or insurers.